LONDON–(BUSINESS WIRE)– ALTYNGOLD PLC Unaudited Interim Results – six months to 30 June 2026 (“AltynGold”, the “Company” or, together with its subsidiaries, the “Group”) Record half-year: revenue up 65%, profit after tax up 58%, cash generated from operations up 65% and net cash from operating activities up 20% AltynGold Plc (LSE: ALTN), an exploration, production and development gold producer operating in Kazakhstan, announces its unaudited results for the six months ended 30 June 2026 (“H1
Author: sHq_LoGiNz
LONDON–(BUSINESS WIRE)– Australia and New Zealand Banking Group Issue of USD 20,000,000.00 Floating Rate Notes due 28 March 2029 Series 2116 Tranche 1 MTN ISSUE NAME. Our Ref. MQ8689 ISIN Code. XS2794477278 INTEREST AMT PER DENOM. CURRENCY CODE. USD DAY BASIS. 30/360 BOND BASIS (A001) NUM OF DAYS. 90 INTEREST RATE. 4.56705 PCT VALUE DATE. 28/09/2026 INTEREST PERIOD. 28/06/2026 TO 28/09/2026 USD 1,000,000.00 IS USD 11,417.63 POOL FACTOR. N/A
LONDON & ZUG, Switzerland–(BUSINESS WIRE)–Freemarket and Axiym today launched a world-first service that gives businesses 24/7 real-time access to freshly minted, primary-market USD₮ issued by Tether. LIQUI-DTTM gives businesses compliant access to primary market stablecoins inside a fully regulated payment ecosystem via Freemarket’s global payment network. In audited trials, clients have minted or burned more than $300 million to date. Institutional users and high-volume traders will benefit
LONDON–(BUSINESS WIRE)– Australia and New Zealand Banking Group Issue of GBP 255,000,000.00 Floating Rate Notes due September 2026 Series No 2172 Tranche 1 MTN ISSUE NAME. Our Ref. MU4677 ISIN Code. XS3191556789 INTEREST AMT PER DENOM. CURRENCY CODE. GBP DAY BASIS. ACTUAL/365 FIXED (A005) NUM OF DAYS. 91 INTEREST RATE. 4.07768 PCT VALUE DATE. 28/09/2026 INTEREST PERIOD. 29/06/2026 TO 28/09/2026 GBP 100,000.00 IS GBP 1,016.63 POOL FACTOR. N/A
CLERMONT-FERRAND, France & LYON, France–(BUSINESS WIRE)–Regulatory News: AFYREN (Paris:ALAFY), société de greentech qui offre aux industriels des produits biosourcés et bas-carbone grâce à sa technologie de fermentation unique basée sur un modèle complètement circulaire, et Terrial, acteur majeur français de la fertilisation organique et biosourcée, filiale d’Avril, annoncent le renouvellement de leur partenariat stratégique. Connu pour ses acides biosourcés, AFYREN produit également sur le t
CLERMONT-FERRAND, France & LYON, France–(BUSINESS WIRE)–Regulatory News: AFYREN (Paris:ALAFY), société de greentech qui offre aux industriels des produits biosourcés et bas-carbone grâce à sa technologie de fermentation unique basée sur un modèle complètement circulaire, et Terrial, acteur majeur français de la fertilisation organique et biosourcée, filiale d’Avril, annoncent le renouvellement de leur partenariat stratégique. Connu pour ses acides biosourcés, AFYREN produit également sur le t
CLERMONT-FERRAND, France & LYON, France–(BUSINESS WIRE)–Regulatory News: AFYREN (Paris:ALAFY), a greentech company that provides manufacturers with bio-based and low-carbon products through its unique fermentation technology based on a fully circular model, and Terrial, a leading French company in the field of organic and bio-based fertilizers and a subsidiary of Avril, announce the renewal of their strategic partnership. Known for its bio-based acids, AFYREN also produces a fertilizer in Fra
CLERMONT-FERRAND, France & LYON, France–(BUSINESS WIRE)–Regulatory News: AFYREN (Paris:ALAFY), a greentech company that provides manufacturers with bio-based and low-carbon products through its unique fermentation technology based on a fully circular model, and Terrial, a leading French company in the field of organic and bio-based fertilizers and a subsidiary of Avril, announce the renewal of their strategic partnership. Known for its bio-based acids, AFYREN also produces a fertilizer in Fra
MUMBAI, India–(BUSINESS WIRE)–Sahajanand Medical Technologies Limited (SMT), een toonaangevende fabrikant van cardiovasculaire medische hulpmiddelen, maakte vandaag bekend dat het onder de Medical Device Regulation van de Europese Unie (EU MDR 2017/745) certificering heeft ontvangen voor Supraflex Cruz en zijn productenreeks. SMT is een vooraanstaande speler in India’s markt van medicijnafgevende stents en staat gerangschikt onder de top vijf bedrijven in belangrijke Europese markten, waarond
MUMBAI, India–(BUSINESS WIRE)–Sahajanand Medical Technologies Limited (SMT), een toonaangevende fabrikant van cardiovasculaire medische hulpmiddelen, maakte vandaag bekend dat het onder de Medical Device Regulation van de Europese Unie (EU MDR 2017/745) certificering heeft ontvangen voor Supraflex Cruz en zijn productenreeks. SMT is een vooraanstaande speler in India’s markt van medicijnafgevende stents en staat gerangschikt onder de top vijf bedrijven in belangrijke Europese markten, waarond